$252 Million is the total value of PURA VIDA INVESTMENTS, LLC's 69 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 291.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EVHC | Buy | ENVISION HEALTHCARE CORP | $11,732,000 | +36.7% | 187,200 | +33.7% | 4.66% | +83.5% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $11,658,000 | +28.4% | 420,546 | +15.2% | 4.63% | +72.4% |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $11,153,000 | – | 174,700 | +100.0% | 4.43% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $10,721,000 | +31.0% | 88,112 | +30.5% | 4.26% | +75.9% |
| LH | New | LABORATORY CORP AMER HLDGS | $10,019,000 | – | 65,000 | +100.0% | 3.98% | – |
| LIVN | New | LIVANOVA PLC | $8,570,000 | – | 140,002 | +100.0% | 3.40% | – |
| MRK | New | MERCK & CO INCput | $8,332,000 | – | 130,000 | +100.0% | 3.31% | – |
| MRK | New | MERCK & CO INC | $8,332,000 | – | 130,000 | +100.0% | 3.31% | – |
| AZN | New | ASTRAZENECA PLCcall | $6,818,000 | – | 200,000 | +100.0% | 2.71% | – |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $6,586,000 | +132.2% | 398,206 | +179.0% | 2.62% | +211.7% |
| CLVS | Buy | CLOVIS ONCOLGY INC | $6,554,000 | +229.3% | 70,000 | +124.0% | 2.60% | +341.8% |
| MRK | New | MERCK & CO INCcall | $6,409,000 | – | 100,000 | +100.0% | 2.54% | – |
| ATHN | New | ATHENAHEALTH INC | $6,044,000 | – | 43,000 | +100.0% | 2.40% | – |
| PRAH | New | PRA HEALTH SCIENCES INC | $5,438,000 | – | 72,500 | +100.0% | 2.16% | – |
| QGEN | Buy | QIAGEN NV | $5,261,000 | +19.1% | 156,900 | +2.9% | 2.09% | +59.8% |
| ABCO | New | ADVISORY BRD CO | $5,150,000 | – | 100,000 | +100.0% | 2.04% | – |
| ISRG | New | INTUITIVE SURGICAL INCcall | $4,677,000 | – | 5,000 | +100.0% | 1.86% | – |
| TSRO | New | TESARO INC | $4,182,000 | – | 29,900 | +100.0% | 1.66% | – |
| NUVA | New | NUVASIVE INCcall | $3,846,000 | – | 50,000 | +100.0% | 1.53% | – |
| EW | New | EDWARDS LIFESCIENCES CORPcall | $3,547,000 | – | 30,000 | +100.0% | 1.41% | – |
| GILD | New | GILEAD SCIENCES INC | $3,539,000 | – | 50,000 | +100.0% | 1.40% | – |
| AXGN | Buy | AXOGEN INC | $3,004,000 | +478.8% | 179,369 | +260.9% | 1.19% | +679.7% |
| CLVS | New | CLOVIS ONCOLGY INCput | $2,809,000 | – | 30,000 | +100.0% | 1.12% | – |
| WMGI | New | WRIGHT MED GROUP N Vcall | $2,749,000 | – | 100,000 | +100.0% | 1.09% | – |
| BRKR | New | BRUKER CORP | $2,354,000 | – | 81,617 | +100.0% | 0.94% | – |
| ARRY | Buy | ARRAY BIOPHARMA INC | $2,223,000 | +11.5% | 265,589 | +19.1% | 0.88% | +49.7% |
| TSRO | New | TESARO INCcall | $1,832,000 | – | 13,100 | +100.0% | 0.73% | – |
| HZNP | New | HORIZON PHARMA PLC | $1,781,000 | – | 150,000 | +100.0% | 0.71% | – |
| VRAY | New | VIEWRAY INC | $1,687,000 | – | 260,670 | +100.0% | 0.67% | – |
| EPZM | New | EPIZYME INC | $1,510,000 | – | 100,000 | +100.0% | 0.60% | – |
| VIVE | Buy | VIVEVE MED INC | $1,437,000 | +16.9% | 200,132 | +3.1% | 0.57% | +57.3% |
| STDY | Buy | STEADYMED LTD | $1,356,000 | +194.1% | 215,214 | +170.9% | 0.54% | +295.6% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DELcall | $1,192,000 | +27.9% | 267,800 | +33.9% | 0.47% | +71.4% |
| SVRA | New | SAVARA INC | $1,176,000 | – | 200,000 | +100.0% | 0.47% | – |
| CDTX | New | CIDARA THERAPEUTICS INC | $1,125,000 | – | 150,000 | +100.0% | 0.45% | – |
| NEOS | New | NEOS THERAPEUTICS INC | $1,095,000 | – | 150,000 | +100.0% | 0.44% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $1,011,000 | – | 30,000 | +100.0% | 0.40% | – |
| ESRX | New | EXPRESS SCRIPTS HLDG COcall | $958,000 | – | 15,000 | +100.0% | 0.38% | – |
| AGEN | New | AGENUS INCcall | $782,000 | – | 200,000 | +100.0% | 0.31% | – |
| AGRX | Buy | AGILE THERAPEUTICS INC | $654,000 | +24.1% | 174,501 | +6.1% | 0.26% | +66.7% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $590,000 | – | 35,000 | +100.0% | 0.23% | – |
| RGNX | New | REGENXBIO INC | $569,000 | – | 28,820 | +100.0% | 0.23% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $556,000 | – | 100,000 | +100.0% | 0.22% | – |
| ABCO | New | ADVISORY BRD COcall | $227,000 | – | 4,400 | +100.0% | 0.09% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $222,000 | – | 100,000 | +100.0% | 0.09% | – |
| DFFN | New | DIFFUSION PHARMACEUTICALS IN | $193,000 | – | 82,816 | +100.0% | 0.08% | – |
| XENT | New | INTERSECT ENT INCcall | $126,000 | – | 4,500 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.